hsa-miR-93-5p

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

CDKN1A

Drug

Vincristine

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Description

The results of the present study suggest that miR-93-5p serves a role in the development of MDR through downregulating CDKN1A gene expression in CRC.

Tissue resource

human gastric cancer cell lines MKN45

human gastric cancer cell lines MKN28

Experiment

qRT-PCR,Western blot

Country

Continent